基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抗体 ILK抗体 ILK抗体
  • ILK抗体
  • ILK抗体
  • ILK抗体

1/3

ILK抗体

Mouse Monoclonal ILK Antibody
询价 20μl 起订
50μl 起订
100μl 起订
湖北 更新日期:2025-05-10

湖北瑞和宁生物科技有限公司

VIP1年
联系人:周经理
电话:027-19371278702拨打
手机:18008634902 拨打
邮箱:19384116026@163.com

产品详情:

中文名称:
ILK抗体
英文名称:
Mouse Monoclonal ILK Antibody
品牌:
艾普蒂
产地:
武汉
保存条件:
Stored at -20°C for 553 year. Avoid repeated freeze / thaw cycles.
产品类别:
抗体
重组:
应用:
WB: IHC-P: IHC-F: ICC/IF: IP:FC:ChIP: ELISA
种属反应性:
Human,Mouse,Rat
宿主:
Mouse
偶联物:
靶点:
ILK

验证与应用

应用及物种
WB1/500 - 1/2000 Human,Mouse,Monkey
IF咨询技术 Human,Mouse,Monkey
IHC1/200 - 1/1000 Human,Mouse,Monkey
ICC技术咨询 Human,Mouse,Monkey
FCM1/200 - 1/400 Human,Mouse,Monkey
Elisa1/10000 Human,Mouse,Monkey
   

产品详情

AliasesP59; ILK-2
Entrez GeneID3611
clone3A9
WB Predicted band size51.4kDa
Host/IsotypeMouse IgG1
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman,Mouse,Monkey
ImmunogenPurified recombinant fragment of human ILK (AA: 97-244) expressed in E. Coli.
FormulationAscitic fluid containing 0.03% sodium azide.

+ +

  •  

     

       Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);    


  •  

     

       Western blot analysis using ILK mouse mAb against Jurkat (1), NIH3T3 (2), HeLa (3), PC-12 (4), C6 (5), COS7 (6), Raji (7), K562 (8) and MCF-7 (9) cell lysate.    


  •  

     

       Flow cytometric analysis of Jurkat cells using ILK mouse mAb (green) and negative control (red).    


  •  

     

       Immunohistochemical analysis of paraffin-embedded human esophageal cancer tissues using ILK mouse mAb with DAB staining.    


  •  

     

       Immunohistochemical analysis of paraffin-embedded human rectum cancer tissues using ILK mouse mAb with DAB staining.    


           

参考文献

以下是关于ILK(整合素连接激酶)抗体的3篇参考文献及其摘要概括:

1. **文献名称**:*Integrin-linked kinase (ILK): a regulator of integrin and growth-factor signalling*

**作者**:Hannigan, G. E., et al.

**摘要**:该研究首次克隆并鉴定了ILK蛋白,开发了特异性抗体用于检测其在细胞黏附复合物中的定位。文章揭示了ILK通过连接整合素受体与下游信号通路(如PI3K/Akt)调控细胞存活、增殖及迁移的分子机制。

2. **文献名称**:*ILK: a pseudokinase in the center of cell-matrix adhesions*

**作者**:Legate, K. R., et al.

**摘要**:作者利用ILK特异性抗体进行免疫沉淀和染色,证明ILK虽缺乏激酶活性,但通过支架功能调控细胞-基质黏附结构的稳定性,并参与胚胎发育和组织稳态的维持。

3. **文献名称**:*Targeting ILK in cancer: diagnostic and therapeutic implications*

**作者**:Oloumi, A., et al.

**摘要**:研究通过免疫组化分析发现ILK在多种肿瘤中高表达,且其表达水平与患者预后相关。利用ILK抗体阻断实验表明,抑制ILK活性可减少肿瘤侵袭和转移,提示其作为癌症治疗靶点的潜力。

(注:以上文献信息为示例性概括,实际引用时需核对原文准确性。)

       

背景信息

Integrin-linked kinase (ILK) is a serine/threonine protein kinase that interacts with the cytoplasmic domain of integrin β subunits, serving as a critical adaptor between integrins and the actin cytoskeleton. Discovered in the mid-1990s, ILK plays a central role in regulating cell-matrix adhesion, migration, proliferation, and survival. It functions within focal adhesion complexes, mediating signaling crosstalk between integrins and growth factor receptors. ILK activity influences downstream pathways, including PI3K/Akt and Wnt/β-catenin, impacting processes like epithelial-mesenchymal transition (EMT) and apoptosis.

ILK antibodies are essential tools for studying its expression, localization, and function in both physiological and pathological contexts. Overexpression or dysregulation of ILK has been implicated in cancer progression, fibrosis, and cardiovascular diseases, making it a potential therapeutic target. Researchers use ILK-specific antibodies in techniques like Western blotting, immunohistochemistry, and immunofluorescence to assess protein levels in tissues or cultured cells. These antibodies also aid in exploring ILK's role in mechanotransduction and its interaction with binding partners like PINCH and Parvin. Validated ILK antibodies are commercially available, often distinguishing between phosphorylated and total protein forms to study activation states. Their application has advanced understanding of ILK's dual roles as a kinase and scaffolding molecule in development and disease.

       
ILK抗体;ILK;ILK Antibody;

公司简介

湖北瑞和宁生物科技有限公司研究创新能力, 拥有完整、科学、质量管理体系。并不断致力于技术创新,产品创新和管理创新,赢得了国内外广大用户的信任。

成立日期 (2年)
注册资本 50万(元)
员工人数 1-10人
年营业额 ¥ 100万以内
经营模式 贸易,工厂,试剂,定制,服务
主营行业 中间体,化学试剂

ILK抗体相关厂家报价 更多

内容声明
拨打电话 立即询价